ACE2 and Werner syndrome: Accordingly, while the exact mechanisms underlying LIR’s neuroprotective effects in WS remain to be fully elucidated, they may include ameliorating reactive gliosis by modulating GABAergic signalling and/or augmenting ACE2 activity [33].